Murphy Andrew Jinsider trades
In SEC Form 4 filings, Murphy Andrew J is listed as Co-Chief Scientific Officer of Regeneron Pharmaceuticals, Inc. (REGN). In the last 90 days, Murphy Andrew J sold $3.20M of Regeneron Pharmaceuticals, Inc. (REGN) on the open market and bought none. All 27 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | Co-Chief Scientific Officer | 30 | Oct 15 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-15
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 6 | $753.76 | Sale −$4,523 | 51,974 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 35 | $755.91 | Sale −$26,457 | 51,939 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 16 | $757.68 | Sale −$12,123 | 51,923 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 24 | $758.16 | Sale −$18,196 | 51,899 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 14 | $759.96 | Sale −$10,639 | 51,885 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 74 | $760.65 | Sale −$56,288 | 51,811 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 27 | $761.36 | Sale −$20,557 | 51,784 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 55 | $762.57 | Sale −$41,941 | 51,729 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 25 | $763.76 | Sale −$19,094 | 51,704 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 219 | $764.40 | Sale −$167,404 | 51,485 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 271 | $765.39 | Sale −$207,421 | 51,214 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 279 | $766.47 | Sale −$213,845 | 50,935 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 192 | $767.39 | Sale −$147,339 | 50,743 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 105 | $768.33 | Sale −$80,675 | 50,638 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 127 | $769.30 | Sale −$97,701 | 50,511 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 12 | $770.20 | Sale −$9,242 | 50,499 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 283 | $771.56 | Sale −$218,351 | 50,216 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 211 | $772.56 | Sale −$163,010 | 50,005 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 224 | $773.40 | Sale −$173,242 | 49,781 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 121 | $774.48 | Sale −$93,712 | 49,660 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 376 | $775.46 | Sale −$291,573 | 49,284 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 66 | $776.31 | Sale −$51,236 | 49,218 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 38 | $777.76 | Sale −$29,555 | 49,180 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 454 | $778.64 | Sale −$353,503 | 48,726 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 380 | $779.59 | Sale −$296,244 | 48,346 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 463 | $780.63 | Sale −$361,432 | 47,883 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 14 | Oct 15 | S | 50 | $781.47 | Sale −$39,074 | 47,833 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 13 | Oct 15 | M | 17,000 | $381.92 | $6,492,640 | 64,833 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 13 | Oct 15 | F | 12,853 | $754.58 | $9,698,617 | 51,980 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Oct 13 | Oct 15 | M · derivative | 17,000 | $381.92 | $6,492,640 | 17,000 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.